nonnutritive suckling
PreclinicalSmall molecule
nonnutritive suckling is one of 12 small molecule programs targeting Pain Management. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
11
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
14 competitors in Pain Management
#DrugCompanyPhaseTrials
1Naropin
FFresenius Kabi USA, LLC
Approved
Keterol
PPamukkale University
Phase 3
Toradol
JJavelin Pharmaceuticals
Phase 2
Bupivacaine-Epinephrine
UUniversity of Aarhus
Phase 3
Ginger
UUniversity of Rochester
Phase 3
Psilocybin
COMPASS PathwaysPhase 1
Bupivacain
IIstanbul University
Preclinical
Bupivacaine %0.25 (isobaric)
UUniversity of Novi Sad
Preclinical
Standard Preparation
LLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Preclinical
Pennsaid
MMallinckrodt
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Pain Management1 trial
Nonpharmacological Pain Management in Neonates
Unknown status·—·N/A·NCT06155825·164 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for nonnutritive suckling. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- AAssiut University